Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

NCT01296932

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Brussels - UNIV Saint-Luc Brussels, Belgium

Edegem - UNIV UZ Antwerpen Edegem, Belgium

UNIV UZ Gent Ghent, Belgium

INS Paoli-Calmettes Marseille, France

View Trial Details

Completed

Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies

NCT02694913

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)

NCT01889069

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica Bari, Apulia, Italy

Azienda ospedaliera oo rr di foggi; Hematology Foggia, Apulia, Italy

Irccs Crob Rionero in Vulture, Basilicate, Italy

Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia Reggio Calabria, Calabria, Italy

View all 39 locations

View Trial Details

Completed

A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients

NCT01561833

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia

NCT01869777

Conditions: Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +27 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT02222688

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

NCT00002715

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

NCT02867566

Conditions: Diffuse, Large B-Cell, Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Institute of Hematology; Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Completed

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

NCT01885897

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +28 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

Washington University St Louis, Missouri, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma

NCT01542918

Conditions: Disease Attributes, Eye Neoplasms, Hemic and Lymphatic Diseases, +13 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions